Correlation Between Acumen Pharmaceuticals and Karyopharm Therapeutics
Can any of the company-specific risk be diversified away by investing in both Acumen Pharmaceuticals and Karyopharm Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acumen Pharmaceuticals and Karyopharm Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acumen Pharmaceuticals and Karyopharm Therapeutics, you can compare the effects of market volatilities on Acumen Pharmaceuticals and Karyopharm Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acumen Pharmaceuticals with a short position of Karyopharm Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acumen Pharmaceuticals and Karyopharm Therapeutics.
Diversification Opportunities for Acumen Pharmaceuticals and Karyopharm Therapeutics
0.47 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Acumen and Karyopharm is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Acumen Pharmaceuticals and Karyopharm Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Karyopharm Therapeutics and Acumen Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acumen Pharmaceuticals are associated (or correlated) with Karyopharm Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Karyopharm Therapeutics has no effect on the direction of Acumen Pharmaceuticals i.e., Acumen Pharmaceuticals and Karyopharm Therapeutics go up and down completely randomly.
Pair Corralation between Acumen Pharmaceuticals and Karyopharm Therapeutics
Given the investment horizon of 90 days Acumen Pharmaceuticals is expected to generate 1.01 times more return on investment than Karyopharm Therapeutics. However, Acumen Pharmaceuticals is 1.01 times more volatile than Karyopharm Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Karyopharm Therapeutics is currently generating about -0.03 per unit of risk. If you would invest 560.00 in Acumen Pharmaceuticals on August 25, 2024 and sell it today you would lose (323.00) from holding Acumen Pharmaceuticals or give up 57.68% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Acumen Pharmaceuticals vs. Karyopharm Therapeutics
Performance |
| Timeline |
| Acumen Pharmaceuticals |
| Karyopharm Therapeutics |
Acumen Pharmaceuticals and Karyopharm Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Acumen Pharmaceuticals and Karyopharm Therapeutics
The main advantage of trading using opposite Acumen Pharmaceuticals and Karyopharm Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acumen Pharmaceuticals position performs unexpectedly, Karyopharm Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Karyopharm Therapeutics will offset losses from the drop in Karyopharm Therapeutics' long position.| Acumen Pharmaceuticals vs. Eliem Therapeutics | Acumen Pharmaceuticals vs. HCW Biologics | Acumen Pharmaceuticals vs. RenovoRx | Acumen Pharmaceuticals vs. Scpharmaceuticals |
| Karyopharm Therapeutics vs. X4 Pharmaceuticals | Karyopharm Therapeutics vs. Hookipa Pharma | Karyopharm Therapeutics vs. Mereo BioPharma Group | Karyopharm Therapeutics vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |